[Anti-fibrosis effect of IFN-gamma and IFN-alpha on chronic hepatitis B patients].
Li
Xu-hong
XH
Research Center for Liver Diseases of Nanjing Military Region, 180th Hospital of the People's Limitary Army, Quanzhou 362000, China.
Wang
Chong-guo
CG
Pan
Xing-nan
XN
Li
Yi-xin
YX
Zhuang
Yue-peng
YP
D000293:Adolescent; D000328:Adult; D000368:Aged; D005260:Female; D019694:Hepatitis B, Chronic / Q000150:complications*; D006801:Humans; D006820:Hyaluronic Acid / Q000097:blood; D016898:Interferon-alpha / Q000627:therapeutic use*; D007371:Interferon-gamma / Q000627:therapeutic use*; D007797:Laminin / Q000097:blood; D008103:Liver Cirrhosis / Q000097:blood / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D012333:RNA, Messenger / Q000097:blood; D011994:Recombinant Proteins
D016898:Interferon-alpha; D007797:Laminin; D012333:RNA, Messenger; D011994:Recombinant Proteins; D007371:Interferon-gamma; D006820:Hyaluronic Acid